Sales of hormone replacement therapies treating menopausal symptoms have seen a sharp decline in recent years as a result of safety concerns raised by the Women’s Health Initiative (WHI) study in 2002. Coupling this with Pfizer’s acquisition of Wyeth, the leading estrogen manufacturer, the future direction of the market is uncertain.
Reasons to Purchase
* Understand the current and future market value and dynamics
* Identify key growth products in the future marketplace
* Analyze the impact of future market events
N/A
Other selected research from the 'Hormone therapy' category:
Testosterone Replacement Therapy Market Forecast
The testosterone replacement therapy market grew with an impressive compound annual growth rate [CAGR]: 24.3% from 2005 to 2009 to reach $838m sales. While these drugs can reverse the... Learn More
Pipeline and Commercial Insight: Testosterone Replacement Therapy - Topical formulations drive market growth
The testosterone replacement therapy market grew with an impressive compound annual growth rate [CAGR]: 24.3% from 2005 to 2009 to reach $838m sales. While these drugs can reverse the... Learn More